Intratumor Heterogeneity of k-ras and p53 Mutations Among Human Colorectal Adenomas Containing Early Cancer

Intratumor Heterogeneity of k-ras and p53 Mutations Among Human Colorectal Adenomas Containing Early Cancer

Show other versions (1)

Saved in:

Bibliographic Details
Main Author:	Walter Giaretti
Format:	Article
Language:	English
Published:	Wiley 2001-01-01
Series:	Analytical Cellular Pathology
Online Access:	http://dx.doi.org/10.1155/2001/905923
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intratumor Heterogeneity of K-Ras and p53 Mutations among Human Colorectal Adenomas Containing Early Cancer
by: Walter Giaretti, et al.
Published: (2000-01-01)

Chromosomal Instability, Aneuploidy, and Gene Mutations in Human Sporadic Colorectal Adenomas
by: Walter Giaretti, et al.
Published: (2004-01-01)

K-ras2 Activation and Genome Instability Increase Proliferation and Size of FAP Adenomas
by: Anna Rapallo, et al.
Published: (1999-01-01)

A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications
by: Hasan Cagri Yildirim, et al.
Published: (2025-02-01)

The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations
by: Anna Hertel, et al.
Published: (2025-02-01)

p53 protein degradation redefines the initiation mechanisms and drives transitional mutations in colorectal cancer
by: Irene Herranz-Montoya, et al.
Published: (2025-04-01)

Intratumoral heterogeneity and drug resistance in cancer
by: Yue-Chun Fu, et al.
Published: (2025-03-01)

甲状腺癌组织中H-ras 和p53 基因突变
by: 李晓曦　陈国锐　赵国华　赵国强
Published: (1997-01-01)

Oncogenic K-Ras Activates p38 to Maintain Colorectal Cancer Cell Proliferation during MEK Inhibition
by: Winan J. van Houdt, et al.
Published: (2010-01-01)

Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
by: Lucillia Bezu, et al.
Published: (2023-12-01)

Exploring RAS mutation incidence and temporal heterogeneity in metastatic colorectal cancer patients – a single-institution experience utilising circulating tumour DNA
by: George Zarkavelis, et al.
Published: (2024-04-01)

Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
by: Michael Heming, et al.
Published: (2022-09-01)

Morphological heterogeneity of intratumoral macrophages in prostate tumors
by: K. V. Danilko, et al.
Published: (2023-01-01)

RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches
by: Osman Sütcüoğlu, et al.
Published: (2025-06-01)

Can K-ras gene mutation be utilized as prognostic biomarker for colorectal cancer patients receiving chemotherapy? A meta-analysis and systematic review.
by: Yuan-Yi Rui, et al.
Published: (2013-01-01)

In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer
by: Alessia Corrado, et al.
Published: (2025-06-01)

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer
by: Dan Huang, et al.
Published: (2020-10-01)

p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms
by: Junjie Li, et al.
Published: (2021-01-01)

A compilation of 13 patients with metastatic colorectal cancer and concomitant BRAF and RAS family mutations
by: Jigisha Srivastav, et al.
Published: (2025-08-01)

Heterogeneous intratumor irradiation: a new partner for immunotherapy
by: Paul Bergeron, et al.
Published: (2024-12-01)

Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product
by: David Willoughby, et al.
Published: (2025-03-01)

Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers
by: Na Zhang, et al.
Published: (2025-05-01)

KRAS G12V mutation-selective requirement for ACSS2 in colorectal adenoma formation
by: Konstantin Budagyan, et al.
Published: (2025-04-01)

The role and challenges of intratumoral microbiota in colorectal cancer immunotherapy
by: Miao Hao, et al.
Published: (2025-08-01)

Regulation of Caenorhabditis elegans p53/CEP-1-dependent germ cell apoptosis by Ras/MAPK signaling.
by: Rachael Rutkowski, et al.
Published: (2011-08-01)

Frequent mutation of K-RAS in addition to BRAF V600E in Ameloblastoma – An immunohistochemical study
by: Aishwariya Mohanty, et al.
Published: (2024-06-01)

Association of various RAS codon mutations and prognostic outcomes of patients with colorectal liver metastases after hepatectomy
by: Xiao‐Gang Wu, et al.
Published: (2024-10-01)

Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53.
by: Emily H Hall, et al.
Published: (2014-01-01)

Comparision Of BRAF V600E, COX–2 and p53 As Biomarkers For The Early Detection Of Colorectal Cancer
by: Hina Wasti, et al.
Published: (2019-06-01)

Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung Adenocarcinoma
by: Benedikt Niedermaier, et al.
Published: (2025-01-01)

The intratumoral microbiota heterogenicity is related to the prognosis and tumorigenesis of cervical cancer
by: Yi Guo, et al.
Published: (2025-05-01)

Detecting PI3K and TP53 Pathway Disruptions in Early‐Onset Colorectal Cancer Among Hispanic/Latino Patients
by: Cecilia Monge, et al.
Published: (2025-04-01)

PHD1 regulates p53‐mediated colorectal cancer chemoresistance
by: Sofie Deschoemaeker, et al.
Published: (2015-08-01)

Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study
by: Mai O Kadry, et al.
Published: (2024-12-01)

Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic.
by: Glen J Weiss, et al.
Published: (2014-01-01)

The distinct conformational dynamics of K-Ras and H-Ras A59G.
by: Suryani Lukman, et al.
Published: (2010-09-01)

Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
by: Yupeng Jiang, et al.
Published: (2025-02-01)

Intratumoral heterogeneity in breast cancer – a real challenge for diagnosis and treatment
by: Marius Pirciu, et al.
Published: (2022-01-01)

Validation of a Compact and Self-Contained Pyrosequencing Platform for Clinical Screening of <i>RAS</i> Mutations in Thyroid Cancers
by: Anne Burkhardt, et al.
Published: (2025-02-01)

Abdominal obesity as the colorectal adenomas risk factor
by: K. N. Mylytsya, et al.
Published: (2016-10-01)